Effects of Intensive Glucose Lowering in Type 2 Diabetes | Zendy

Hertzel C. Gerstein | Zendy; Michael E. Miller | Zendy; Robert P. Byington | Zendy; David C. Goff | Zendy; J. Thomas Bigger | Zendy; John B. Buse | Zendy; William C. Cushman | Zendy; Saul Genuth | Zendy; Faramarz IsmailBeigi | Zendy; Richard H. Grimm | Zendy; Jeffrey L. Probstfield | Zendy; Denise G. SimonsMorton | Zendy; William T. Friedewald | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Intensive Glucose Lowering in Type 2 Diabetes

Author(s) -

Hertzel C. Gerstein,

Michael E. Miller,

Robert P. Byington,

David C. Goff,

J. Thomas Bigger,

John B. Buse,

William C. Cushman,

Saul Genuth,

Faramarz IsmailBeigi,

Richard H. Grimm,

Jeffrey L. Probstfield,

Denise G. SimonsMorton,

William T. Friedewald

Publication year - 2008

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0802743

Subject(s) - medicine , glycated hemoglobin , hazard ratio , type 2 diabetes , confidence interval , discontinuation , diabetes mellitus , myocardial infarction , randomized controlled trial , endocrinology

Epidemiologic studies have shown a relationship between glycated hemoglobin levels and cardiovascular events in patients with type 2 diabetes. We investigated whether intensive therapy to target normal glycated hemoglobin levels would reduce cardiovascular events in patients with type 2 diabetes who had either established cardiovascular disease or additional cardiovascular risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research